Bielekova B - Search Results

1

Molecular-based diagnosis of multiple sclerosis and its progressive stage.

Barbour C, Kosa P, Komori M, Tanigawa M, Masvekar R, Wu T, Johnson K, Douvaras P, Fossati V, Herbst R, Wang Y, Tan K, Greenwood M, Bielekova B. Barbour C, et al. Among authors: bielekova b. Ann Neurol. 2017 Nov;82(5):795-812. doi: 10.1002/ana.25083. Ann Neurol. 2017. PMID: 29059494 Free PMC article.

2

Multiple Sclerosis: Immunotherapy.

Bielekova B, Martin R. Bielekova B, et al. Curr Treat Options Neurol. 1999 Jul;1(3):201-220. doi: 10.1007/s11940-999-0004-x. Curr Treat Options Neurol. 1999. PMID: 11096710

3

Complex immunomodulatory effects of interferon-beta in multiple sclerosis include the upregulation of T helper 1-associated marker genes.

Wandinger KP, Stürzebecher CS, Bielekova B, Detore G, Rosenwald A, Staudt LM, McFarland HF, Martin R. Wandinger KP, et al. Among authors: bielekova b. Ann Neurol. 2001 Sep;50(3):349-57. doi: 10.1002/ana.1096. Ann Neurol. 2001. PMID: 11558791

4

Molecular tracking of antigen-specific T cell clones in neurological immune-mediated disorders.

Muraro PA, Wandinger KP, Bielekova B, Gran B, Marques A, Utz U, McFarland HF, Jacobson S, Martin R. Muraro PA, et al. Among authors: bielekova b. Brain. 2003 Jan;126(Pt 1):20-31. doi: 10.1093/brain/awg021. Brain. 2003. PMID: 12477694 Free PMC article.

5

Longitudinal MRI study: the effects of azathioprine in MS patients refractory to interferon beta-1b.

Markovic-Plese S, Bielekova B, Kadom N, Leist TP, Martin R, Frank JA, McFarland HF. Markovic-Plese S, et al. Among authors: bielekova b. Neurology. 2003 Jun 10;60(11):1849-51. doi: 10.1212/01.wnl.0000071218.34009.af. Neurology. 2003. PMID: 12796549 Clinical Trial.

6

Humanized anti-CD25 (daclizumab) inhibits disease activity in multiple sclerosis patients failing to respond to interferon beta.

Bielekova B, Richert N, Howard T, Blevins G, Markovic-Plese S, McCartin J, Frank JA, Würfel J, Ohayon J, Waldmann TA, McFarland HF, Martin R. Bielekova B, et al. Proc Natl Acad Sci U S A. 2004 Jun 8;101(23):8705-8. doi: 10.1073/pnas.0402653101. Epub 2004 May 25. Proc Natl Acad Sci U S A. 2004. PMID: 15161974 Free PMC article. Clinical Trial.

7

Development of biomarkers in multiple sclerosis.

Bielekova B, Martin R. Bielekova B, et al. Brain. 2004 Jul;127(Pt 7):1463-78. doi: 10.1093/brain/awh176. Epub 2004 Jun 4. Brain. 2004. PMID: 15180926 Review.

8

MRI as a marker for disease heterogeneity in multiple sclerosis.

Bielekova B, Kadom N, Fisher E, Jeffries N, Ohayon J, Richert N, Howard T, Bash CN, Frank JA, Stone L, Martin R, Cutter G, McFarland HF. Bielekova B, et al. Neurology. 2005 Oct 11;65(7):1071-6. doi: 10.1212/01.wnl.0000178984.30534.f9. Neurology. 2005. PMID: 16217061

9

Effect of anti-CD25 antibody daclizumab in the inhibition of inflammation and stabilization of disease progression in multiple sclerosis.

Bielekova B, Howard T, Packer AN, Richert N, Blevins G, Ohayon J, Waldmann TA, McFarland HF, Martin R. Bielekova B, et al. Arch Neurol. 2009 Apr;66(4):483-9. doi: 10.1001/archneurol.2009.50. Arch Neurol. 2009. PMID: 19364933 Free PMC article. Clinical Trial.

10

Evolution of the blood-brain barrier in newly forming multiple sclerosis lesions.

Gaitán MI, Shea CD, Evangelou IE, Stone RD, Fenton KM, Bielekova B, Massacesi L, Reich DS. Gaitán MI, et al. Among authors: bielekova b. Ann Neurol. 2011 Jul;70(1):22-9. doi: 10.1002/ana.22472. Epub 2011 Jun 27. Ann Neurol. 2011. PMID: 21710622 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

111 results

Search Page

Filters